Changing patterns of mortality across Europe in patients infected with HIV-1
- 1 November 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9142) , 1725-1730
- https://doi.org/10.1016/s0140-6736(98)03201-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trialThe Lancet, 1997
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individualsThe Lancet, 1996
- Impact of AIDS on premature mortality in Amsterdam, 1982–1992AIDS, 1994
- Premature mortality related to AIDS among men and women in CataloniaAIDS, 1993
- Excess mortality associated with the HIV epidemic in England and Wales.BMJ, 1991